PortfoliosLab logo
BlackRock Health Sciences Trust II (BMEZ)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US09260E1055

CUSIP

09260E105

IPO Date

Jan 29, 2020

Highlights

Market Cap

$1.48B

EPS (TTM)

$0.21

PE Ratio

69.52

Year Range

$12.43 - $16.17

Short %

0.44%

Short Ratio

0.89

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BlackRock Health Sciences Trust II, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%December2025FebruaryMarchAprilMay
12.88%
73.03%
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Returns By Period

BlackRock Health Sciences Trust II (BMEZ) returned 3.85% year-to-date (YTD) and 7.65% over the past 12 months.


BMEZ

YTD

3.85%

1M

7.89%

6M

-3.46%

1Y

7.65%

5Y*

2.46%

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of BMEZ, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202515.86%-2.69%-5.01%-0.19%-2.86%3.85%
20245.82%6.45%1.05%-11.32%6.31%1.77%5.09%1.75%-0.28%-1.49%2.66%-6.98%9.55%
20238.48%-3.24%6.02%-1.90%-2.21%5.19%0.40%-4.59%-5.81%-8.56%7.00%5.99%5.07%
2022-14.31%-5.59%-0.16%-12.19%-3.43%-0.83%4.33%-3.19%-7.64%5.52%5.46%-4.47%-32.65%
20211.18%-5.43%-2.90%5.21%3.43%2.70%-1.45%1.84%-5.64%-0.32%-8.71%5.33%-5.76%
20201.40%-1.57%-10.50%9.97%3.59%4.16%8.57%8.11%-1.55%-1.59%17.44%5.11%48.77%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BMEZ is 62, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BMEZ is 6262
Overall Rank
The Sharpe Ratio Rank of BMEZ is 6868
Sharpe Ratio Rank
The Sortino Ratio Rank of BMEZ is 5757
Sortino Ratio Rank
The Omega Ratio Rank of BMEZ is 5555
Omega Ratio Rank
The Calmar Ratio Rank of BMEZ is 6161
Calmar Ratio Rank
The Martin Ratio Rank of BMEZ is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

BlackRock Health Sciences Trust II Sharpe ratios as of May 9, 2025 (values are recalculated daily):

  • 1-Year: 0.40
  • 5-Year: 0.11
  • All Time: 0.09

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of BlackRock Health Sciences Trust II compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
0.40
0.48
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Dividends

Dividend History

BlackRock Health Sciences Trust II provided a 14.25% dividend yield over the last twelve months, with an annual payout of $2.03 per share.


4.00%6.00%8.00%10.00%12.00%$0.00$0.50$1.00$1.5020202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020
Dividend$2.03$1.69$1.58$1.74$1.71$0.90

Dividend yield

14.25%11.74%10.81%11.28%6.75%3.14%

Monthly Dividends

The table displays the monthly dividend distributions for BlackRock Health Sciences Trust II. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.18$0.18$0.18$0.17$0.00$0.71
2024$0.09$0.09$0.09$0.09$0.09$0.18$0.18$0.18$0.18$0.18$0.18$0.18$1.69
2023$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.09$0.09$0.09$1.58
2022$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$1.74
2021$0.10$0.10$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.15$0.21$1.71
2020$0.10$0.10$0.10$0.10$0.10$0.10$0.10$0.10$0.10$0.90

Dividend Yield & Payout


Dividend Yield

BlackRock Health Sciences Trust II has a dividend yield of 14.25%, which means its dividend payment is significantly above the market average.

Payout Ratio

BlackRock Health Sciences Trust II has a payout ratio of 316.36%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-29.61%
-7.82%
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the BlackRock Health Sciences Trust II. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BlackRock Health Sciences Trust II was 46.05%, occurring on May 11, 2022. The portfolio has not yet recovered.

The current BlackRock Health Sciences Trust II drawdown is 29.61%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.05%Feb 16, 2021313May 11, 2022
-39.45%Feb 12, 202025Mar 18, 202075Jul 6, 2020100
-9.99%Sep 2, 20204Sep 8, 202019Oct 5, 202023
-8.46%Oct 14, 202013Oct 30, 20204Nov 5, 202017
-8.29%Jan 21, 20218Feb 1, 20219Feb 12, 202117

Volatility

Volatility Chart

The current BlackRock Health Sciences Trust II volatility is 9.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%December2025FebruaryMarchAprilMay
9.26%
11.21%
BMEZ (BlackRock Health Sciences Trust II)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BlackRock Health Sciences Trust II over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of BlackRock Health Sciences Trust II, comparing actual results with analytics estimates.


-5.000.005.00JulyOctober2021AprilJulyOctober2022AprilJulyOctober
0.67
0
Actual
Estimate

Valuation

The Valuation section provides an overview of how BlackRock Health Sciences Trust II is priced in the market compared to other companies in the Capital Markets industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for BMEZ, comparing it with other companies in the Capital Markets industry. Currently, BMEZ has a P/E ratio of 69.5. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BMEZ relative to other companies in the Capital Markets industry. Currently, BMEZ has a P/S ratio of 60.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BMEZ in comparison with other companies in the Capital Markets industry. Currently, BMEZ has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items